Wayne Williams Acquires 13,689 Shares of Callan JMB (NASDAQ:CJMB) Stock

Key Points

  • CEO Wayne Williams purchased 30,856 shares of Callan JMB on Dec. 11 at an average price of $1.65, a $50,912.40 transaction that raised his stake 81.87% to 68,545 shares (valued at about $113,099).
  • Callan JMB is a small-cap company (market cap ~$8.2 million) with weak recent results, reporting a quarterly EPS of ($0.61), a negative return on equity of 133.43%, and a negative net margin of 112.72%.
  • Market sentiment is negative: Weiss Ratings reissued a "sell (e+)" and MarketBeat shows a consensus "Sell," although institutional investor HighTower Advisors recently initiated a 12,500-share position.

Callan JMB Inc. (NASDAQ:CJMB - Get Free Report) CEO Wayne Williams purchased 13,689 shares of the business's stock in a transaction dated Wednesday, December 10th. The stock was bought at an average cost of $1.65 per share, with a total value of $22,586.85. Following the completion of the acquisition, the chief executive officer directly owned 38,689 shares of the company's stock, valued at approximately $63,836.85. This trade represents a 54.76% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Callan JMB Stock Down 1.9%

CJMB traded down $0.04 during trading on Friday, reaching $1.78. 26,689 shares of the company were exchanged, compared to its average volume of 43,950. Callan JMB Inc. has a 12-month low of $1.20 and a 12-month high of $7.76. The company's 50-day moving average is $3.40 and its two-hundred day moving average is $4.38. The company has a market cap of $8.20 million and a price-to-earnings ratio of -1.43.

Callan JMB (NASDAQ:CJMB - Get Free Report) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.61) earnings per share for the quarter. Callan JMB had a negative net margin of 112.72% and a negative return on equity of 133.43%. The company had revenue of $1.45 million for the quarter.

Institutional Inflows and Outflows




An institutional investor recently bought a new position in Callan JMB stock. HighTower Advisors LLC purchased a new position in shares of Callan JMB Inc. (NASDAQ:CJMB - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 12,500 shares of the company's stock, valued at approximately $56,000. HighTower Advisors LLC owned approximately 0.28% of Callan JMB at the end of the most recent reporting period.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of Callan JMB in a research report on Monday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of "Sell".

Read Our Latest Report on CJMB

Callan JMB Company Profile

(Get Free Report)

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.

Further Reading

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Callan JMB?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Callan JMB and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles